TimothyPCripeMDPhD

Pediatric Hematology & Oncology • Columbus, OH

Professor, Pediatrics, Ohio State University College of Medicine

Join to view full profile

Dr. Cripe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cripe's full profile

Already have an account?

Office
700 Childrens Dr
Columbus, OH 43205
Phone+1 614-722-3552

Fax+1 614-722-3699

Education & Training

University of ColoradoFellowship, Pediatric Hematology/Oncology, 1993 - 1995
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 1989 - 1992
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1989

Certifications & Licensure

OH State Medical License 1999 - 2027
CO State Medical License 1993 - 2009
WI State Medical License 1995 - 2001
IL State Medical License 1995 - 1999
IA State Medical License 1989 - 1994
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014-2020

Clinical Trials

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors Start of enrollment: 2010 Mar 01
Completed
Phase 1
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients Start of enrollment: 2010 Aug 01
Completed
Phase 1
Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors Start of enrollment: 2017 Apr 17
Completed
Phase 1

Publications & Presentations

PubMed

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma.
Yaya Chu, Meijuan Tian, Uksha Saini, Jessica Ayala-Cuesta, Kayleigh Klose
Molecular Therapy. Oncology. 2025-03-20
1 citations
Trabectedin enhances the antitumor effects of IL-12 in triple-negative breast cancer.
Emily Schwarz, Himanshu Savardekar, Sara Zelinskas, Abigail Mouse, Gabriella Lapurga
Cancer Immunology Research. 2025-01-07
Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma.
Safiya Khurshid, Akila S Venkataramany, Matias Montes, John F Kipp, Ryan D Roberts
Molecular Therapy. Oncology. 2024-12-19

Press Mentions

Columbus Cancer Programs Invest in the Future of CareMarch 12th, 2025
TWiPO #93: CureWorks & Caring Cross: Pathways to Advance Cell & Gene Therapy with Dr. Rimas OrentasJanuary 20th, 2022
Collaboration Between Rheumatologists, Primary Care Reduces Delay in Axial SpA DiagnosisAugust 4th, 2021
Join now to see all

Grant Support

A New Paradigm to Prevent and Treat MicrometastasesRESEARCH INST NATIONWIDE CHILDREN'S HOSP2024–2029
A New Paradigm to Prevent and Treat MicrometastasesRESEARCH INST NATIONWIDE CHILDREN'S HOSP2024–2029
Training Program in Basic and Translational Pediatric Oncology ResearchRESEARCH INST NATIONWIDE CHILDREN'S HOSP2022–2027
Training Program in Basic and Translational Pediatric Oncology ResearchRESEARCH INST NATIONWIDE CHILDREN'S HOSP2022–2027
Training Program in Basic and Translational Pediatric Oncology ResearchRESEARCH INST NATIONWIDE CHILDREN'S HOSP2022–2027
Training Program in Basic and Translational Pediatric Oncology ResearchRESEARCH INST NATIONWIDE CHILDREN'S HOSP2022–2027
Training Program in Basic and Translational Pediatric Oncology ResearchRESEARCH INST NATIONWIDE CHILDREN'S HOSP2022–2027
Training Program in Basic and Translational Pediatric Oncology ResearchRESEARCH INST NATIONWIDE CHILDREN'S HOSP2022–2027
Training Program in Basic and Translational Pediatric Oncology ResearchRESEARCH INST NATIONWIDE CHILDREN'S HOSP2022–2027
Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy CenterRESEARCH INST NATIONWIDE CHILDREN'S HOSP2019–2025
Diversity Supplement: Hernandez-Aguirre- Cripe U54RESEARCH INST NATIONWIDE CHILDREN'S HOSP2019–2025
Diversity Supplement: Hernandez-Aguirre- Cripe U54RESEARCH INST NATIONWIDE CHILDREN'S HOSP2019–2025
Diversity Supplement: Hernandez-Aguirre- Cripe U54RESEARCH INST NATIONWIDE CHILDREN'S HOSP2019–2025
Childhood high-risk sarcoma derived human satellite (HSAT) and endogenous retroviral (ERV) RNAs in systemic immunosuppression and inflammationRESEARCH INST NATIONWIDE CHILDREN'S HOSP2019–2025
Xenograft Core For NF1 Experimental TherapeuticsNational Institute Of Neurological Disorders And Stroke2010–2011
Phase I Study Of Hsv1716 In Pediatric Non-Cns Solid Tumors,Ind 13196 12/04/2006Food And Drug Administration2010–2011
Oncolytic HSV Therapy In Immunocompetent Sarcoma ModelsNational Cancer Institute2010
Xenograft Core For NF1 Experimental TherapeuticsNational Institute Of Neurological Disorders And Stroke2008–2009
Virotherapy For Neuroblastoma Stem CellsNational Cancer Institute2008–2009
Oncolytic HSV Therapy In Immunocompetent Sarcoma ModelsNational Cancer Institute2006–2009
Regulated Toxin Gene Therapy For RhabdomyosarcomaNational Cancer Institute1999–2001
Regulated Toxin Gene Therapy For RhabdomyosarcomaNational Cancer Institute1997–1999
HSC 70 And Agnoprotein In Papovavirus AssemblyNational Institute Of Allergy And Infectious Diseases1995–1997